Stock Research: Personalis

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Personalis

NMQ:PSNL US71535D1063
78
  • Value
    84
  • Growth
    100
  • Safety
    Safety
    43
  • Combined
    96
  • Sentiment
    23
  • 360° View
    360° View
    78
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and analytics to support personalized cancer vaccines and immunotherapies. Its main businesses include genomic sequencing and analytics, with products like NeXT Personal, ImmunoID NeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). The company's tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and personalized cancer therapies. In the last fiscal year, the company had a market cap of $563 million, profits of $27 million, revenue of $85 million, and 229 employees.

more

ANALYSIS: With an Obermatt 360° View of 78 (better than 78% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Personalis are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Personalis. The consolidated Value Rank has an attractive rank of 84, which means that the share price of Personalis is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 84% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 100, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 23. Professional investors are more confident in 77% other stocks. Worryingly, the company has risky financing, with a Safety rank of 43. This means 57% of comparable companies have a safer financing structure than Personalis. ...read more

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Aug-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
84 28 85 71
Growth
100 55 39 7
Safety
Safety
43 26 79 90
Sentiment
23 70 64 29
360° View
360° View
78 41 91 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
14 71 67 64
Opinions Change
3 36 50 50
Pro Holdings
n/a 51 41 19
Market Pulse
75 75 51 38
Sentiment
23 70 64 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
84 28 85 71
Growth
100 55 39 7
Safety Safety
43 26 79 90
Combined
96 14 82 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
62 35 91 38
Price vs. Earnings (P/E)
80 88 88 30
Price vs. Book (P/B)
22 43 88 94
Dividend Yield
1 1 1 1
Value
84 28 85 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
57 14 14 8
Profit Growth
51 73 56 26
Capital Growth
82 28 71 87
Stock Returns
83 100 35 7
Growth
100 55 39 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
45 62 68 100
Refinancing
75 47 89 99
Liquidity
26 1 7 1
Safety Safety
43 26 79 90

Similar Stocks

Discover high‑ranked alternatives to Personalis and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Merck (USA)

NYQ:MRK
Country: USA
Industry: Pharmaceuticals
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is a mixed bag with good value and high growth balanced by risky financing and negative sentiment. This is a risky stock that requires conviction; you should only consider it if you are willing to conduct further research into the underlying sentiment and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: